Treatment of Rubeosis iridis with Photodynamic Therapy with Verteporfin – A New Therapeutic and Prophylactic Option for Patients with the Risk of Neovascular Glaucoma?

Publisher： Karger

E-ISSN： 1423-0259|35|1|60-64

ISSN： 0030-3747

Source： Ophthalmic Research, Vol.35, Iss.1, 2003-01, pp. : 60-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Photodynamic therapy with verteporfin: A new treatment in ophthalmology

By Michels Stephan   Schmidt-Erfurth Ursula  

Seminars in Ophthalmology, Vol. 16, Iss. 4, 2001-12 ,pp. : 201-206

Informa Healthcare

Access to resources Recommend Favorite

Ranibizumab plus Verteporfin Photodynamic Therapy in Neovascular Age-Related Macular Degeneration: 12 Months of Retreatment and Vision Outcomes from a Randomized Study

By  

Ophthalmologica, Vol. 233, Iss. 2, 2014-11 ,pp. : 66-73

Karger

Access to resources Recommend Favorite

Trabeculectomy with Mitomycin C for Treatment of Neovascular Glaucoma in Diabetic Patients

By  

Ophthalmologica, Vol. 220, Iss. 6, 2006-11 ,pp. : 383-388

Karger

Access to resources Recommend Favorite

Experimental Inhibition of Corneal Neovascularization by Photodynamic Therapy with Verteporfin

By Yoon Kyung-Chul   Ahn Kyu   Lee Song   Kim Kyung   Im Seong-Kyu   Oh Han-Jin   Jeong In-Young   Park Sang-Woo   Park Yeoung-Geol   Nah Hyeon-Ju   Im Wook-Bin  

Current Eye Research, Vol. 31, Iss. 3, 2006-03 ,pp. : 215-224

Informa Healthcare

Access to resources Recommend Favorite

Photodynamic Therapy with Verteporfin for Polypoidal Choroidal Vasculopathy of the Macula

By  

Ophthalmologica, Vol. 218, Iss. 3, 2004-04 ,pp. : 193-201

Karger

Access to resources Recommend Favorite